Adrenal incidentalomas

Current Opinion in Oncology

Volumn 14, Issue 1, 2002, Pages 58-63

  Bertherat, Jérôme ^a   Mosnier Pudar, Helen ^a   Bertagna, Xavier ^a  

^a université Paris Cité   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6BETA IODOMETHYL 19 NORCHOLEST 5(10) EN 3BETA OL I 131;

ADRENAL CANCER; ADRENAL CORTEX ADENOMA; ADRENAL SCINTISCANNING; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; PATHOGENESIS; PHEOCHROMOCYTOMA; PREVALENCE; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR VOLUME;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENAL GLAND NEOPLASMS; HUMANS;

EID: 0036145107     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200201000-00011     Document Type: Review

References (46)

1. Subclinical hormone secretion by incidentally discovered adrenal masses
2. Incidental asymptomatic adrenal masses detected by computed tomographic scanning
3. Incidentally discovered adrenal tumors: An institutional perspective
4. Endokrin inaktive nebennierentumoren
5. Incidentally discoverad adrenal masses
6. Outcome in patients with adrenal incidentaloma selected for surgery: An analysis of 88 cases investigated in a single clinical center
7. A survey of adrenal incidentaloma in Italy
8. Activating mutations of the stimulatory G protein in the McCune-Albright
9. Pathogenesis of adrenocortical incidentalomas and genetic syndromes associated with adrenocortical neoplasms
10. Genetic heterogeneity and spectrum of mutations of the PRKAR1A gene in patients with the Carney complex
11. Propranolol therapy lor ectopic beta-adrenergic receptors in adrenal Cushing's syndrome
12. Structural and functional abnormalities at the 11p156 locus are associated with malignant phenotype: Study on a series of 82 adrenocortical tumors
13. MEN1 gene analysis in sporadic adrenocortical tumors
14. Genotyping of adrenocortical tumors: Very frequent deletions of the MEN1 locus in 11p13 and of 1-centim-organ region in 2p16
15. Clinically unsuspected pheochromocytomas: Experience of Henry Ford Hospital and review of the literature
16. Méthodes recommandées pour le dosage des catécholamines et de leur métabolites dans l'urine
17. Urinary free coricoids: An evaluation of their usefulness in the diagnosis of Cushing's syndrome
18. Overnight dexamethasone suppression test: Comparaison of plasma and salivary cortisol measurement for the screening of Cushing's syndrome
19. Preclinical Cushing's syndrome in adrenal incidentalomas: Comparaison with adrenal Cushing's syndrome
20. The incidentally discovered asymptomatic cortisol-producing adrenal adenoma pre-Cushing's syndrome
21. Possible pre-Cushing's syndrome due to an adrenal adenoma incidentally discovered
22. Subtle glucocorticoid excess in patients with adrenal incidentaloma
23. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: A marker of adrenocortical tumor
24. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas)
25. Diagnostic approach to incidental adrenal nodules in the cancer patient: Results of clinical, radiologic, and fine-needle aspirat on study
26. Evaluation of adrenal masses in oncologic patients: Dynamic contrast-enhanced MR vs CT
27. Integrated imaging of adrenal disease
28. Accuracy of computed tomography in predicting adrenal tumor size
29. Differentiation between small benign and malignant adrenal masses with dynamic increment CT
30. Benign and malignant adrenal masses: CT distinction with attenuation coefficients, size, and observer analysis
31. CT of adrenal tumor: Frequency and clinical significance of low-attenuation lesions
32. CT appearance of adrenal cortical carcinoma
33. In vivo MR spectroscopic imaging of the adrenal glands: Distinction between adenomas and carcinomas larger than 15 mm based on lipid content
34. In vitro adrenal cortex lesion characterization by NMR spectroscopy
35. Differentiation of malignant from benign adrenal masses: Predictive indices on computed tomography
36. State-of-the-art MR imaging of the adrenal gland
37. Adrenal masses: Differentiation with chemical shift, fast low-angle shot MR imaging
38. Benign adrenocortical masses: Diagnosis with chemical shift MR imaging
39. Place de la scintigraphie corticosurrénalienne dans l'exploration des incidentalomes
40. Differential diagnosis of solid adrenal masses using adrenocortical scintigraphy
41. Scintigraphic evaluation of clinically silent adrenal masses
42. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: Clinical and biochemical featrures
43. The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis
44. Altered bone mass and turnover in female patients with adrenal incidentaloma: The effect of subclinical hypercortisolism
45. Risk factors and long-term follow-up of adrenal incidentalomas
46. Natural course of adrenal incidentalomas: Seven-year follow-up study